Food and Drug Administrations Pharmacy Compounding Advisory Committee (PCAC) will meet July 23-24 to discuss whether several peptide substances should be considered for inclusion on the Section 503A Bulks List, an important regulatory pathway for pharmacy compounding
Adding Ozempic can drop it an additional 1-1.5%
How is Ozempic administered
Future research should include a longer follow-up to investigate sustained treatment effects, and current evidence does not yet support widespread off-label use of semaglutide for AUD
The major players are Kyowa Hakko Bio (Kirin Holdings), Shandong Jincheng, KOHJIN Life Sciences, Kaiping Biochemical Pharmaceutical, Meteoric Biopharmaceuticals Pvt
For urgent concerns, contact your GP, NHS 111, or emergency services if appropriate